Tarptautinis bioterapijos institutas, UAB Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| -3,930 |
| -3,930 |
| - |
| - |
| - |
| -1,430 |
| 1,500 |
| 0 |
| 70 |
| 2024 |
|---|
| 113,081 |
| 37,694 |
| 12,226 |
| 10,974 |
| 3,658 |
| 33.38 |
| 9.70 |
| 9,544 |
| 45,981 |
| 0 |
| 59,944 |
| 2025 |
|---|
| 119,297 |
| 39,766 |
| 8,157 |
| 7,234 |
| 2,411 |
| 41.00 |
| 6.06 |
| 16,778 |
| 47,568 |
| 0 |
| 66,807 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 119,297 |
| 39,766 |
| 8,157 |
| 7,234 |
| 2,411 |
| 41.00 |
| 6.06 |
| 16,778 |
| 47,568 |
| 0 |
| 66,807 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
119,297 €6 % *
Sales per employee (€)
39,766 €6 % *
Profit before tax (€)
8,157 €-33 % *
Net Profit (€)
7,234 €-34 % *
Profit per employee (€)
2,411 €-34 % *
Total profitability (%)
41.00 %22.83 % *
Net profitability (%)
6.06 %-37.53 % *
Equity (€)
16,778 €76 % *
Amounts Payable And Liabilities (€)
47,568 €3 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
66,807 €11 % *
